Patients' persistent symptoms, clinician demographics and geo-economic factors are associated with choice of therapy for hypothyroidism by European thyroid specialists: The "THESIS"* collaboration (* < em > T < /em > reatment of < em > H < /em > ypothyroidism in Europe by < em > S < /em > pecialists, an < em > I < /em > nternational < em > S < /em > urvey)

CONCLUSIONS: The perception of patients' dissatisfaction reported by physicians seems lower than that described by hypothyroid patients in previous surveys. LT4+LT3 treatment is used frequently by thyroid specialists in Europe for persistent hypothyroid-like symptoms even if they generally attribute such symptoms to non-endocrine causes and despite the evidence of non-superiority of the combined over the LT4 therapy. Pressure by dissatisfied patients on their physicians for LT3-containing treatments is a likely explanation. The association of the therapeutic choices with the clinician demographic characteristics and geo-economic factors in Europe is a novel information and requires further investigation.PMID:38368541 | DOI:10.1089/thy.2023.0580
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Authors: Source Type: research